Our Regenerative Medicine Product

Liveyon’s Stem Cells Come From Umbilical Cord Donations.

Liveyon’s Premier MAXCB® regenerative medicine product is derived from Umbilical Cord Donations. Our product contains mesenchymal stem cells (MSCs) and is rich in growth factors from umbilical cord blood. We obtain these tissues under informed consent and strict ethical protocols. The cord from where we extract our stem cells are from safe, reliable hospital sources via a non-invasive, simple, and painless procedure.  
  • Here's how it works: 
  • Participating hospitals invite screened mothers expecting normal, healthy births to donate the resulting umbilical cord tissues. These otherwise discarded tissues are an excellent source of high-quality stem cells and growth factors which may be used in regenerative medicine. At the time of birth, a specialized nurse enters the delivery room to carry out the extraction procedures. The umbilical cord tissue and blood is extracted and taken to our lab which follows cGMP and GTP procedures. From here our regenerative medicine product is made.
  • All the tissues obtained are screened under FDA standards in order to assure the safest and highest quality product. Our regenerative medicine product is sold in standardized concentrations making it easy for physicians to deliver a dependable product.
  • Liveyon is the exclusive worldwide distributor of our partner lab which ships our regenerative medicine product to doctors and clinics worldwide.     

Other Stem Cell Sources

Liveyon’s stem cells are derived exclusively from umbilical cord, which is the safest and least-invasive method of extraction available. Other methods include:  
Embryonic tissue
Most embryonic stem cells (human embryonic stem cells, or hESCs) are derived from embryos donated from fertility clinics that perform in vitro fertilization, or IVF.
Bone marrow
Adult stem cells can be extracted from bone marrow by aspiration, typically from the superior iliac crest or the sternum. This process may be painful, though much research has been done to reduce any pain incurred by patients during extraction.
Adipose tissue
Adipose-derived stem cells come from a patient’s fat tissue, which is surgically extracted via liposuction under general anesthesia.
Liveyon's Premier MAXCB® are strictly screened and sold in standardized concentrations. Using stem cells may give patients a wide range of benefits via procedures that can be conducted in under half an hour.

Why Liveyon Provides Only Umbilical-Cord-Derived Stem Cells

Liveyon's umbilical-cord-derived regenerative medicine product contains MSCs that are both safe and non-invasive for donors, as well as a reliable source for physicians.

Our stem cells also come from the youngest postnatal cells and do not rely upon embryonic tissue (the use of which brings up ethical issue for some doctors and patients). Bone Marrow MSCs are the same age of the donor at the time of extraction.

Umbilical Cord Mesenchymal Stem Cells: The New Gold Standard for Mesenchymal Stem Cell-Based Therapies? 

Stem Cell Treatment Today

Today, doctors in a wide variety of clinical settings include stem cell therapies to treat a myriad of conditions. Typical treatments are simple, safe, do not require anesthesia, and take about the same time as a regular office visit. Stem cells are currently being used in a number of medical applications, including the treatment of:   
  • Rheumatoid arthritis, Crohn’s disease, lupus and other autoimmune disorders
  • Parkinson’s, ALS, Alzheimer’s and other neurological diseases
  • Types I and II diabetes
  • Heart diseases
  • Respiratory disorders
  • Athletic injuries
  • Chronic pain Spinal cord injuries and other orthopedic conditions
  • Orthodontics
  • Dermatological disorders
  • Cosmetic/aesthetic issues treated by cosmetic dermatologists 

Liveyon’s stem cells may be administered in various methods according to your patients needs or according to the practitioners protocol. To learn more or place an order, contact us online or call us at 844-LIVEYON .


Medical Professional Viewing Only (Disclaimer)

This site was intended for education purposes only and strictly for use by medical professionals. The FDA recently re-confirmed, there is only one registered stem cell product, and while there is enormous promise in stem cell therapies, and thousands of ongoing experimental applications trying to establish efficacy, these are not at the point where they would meet the scientific standard.

The FDA has stated:

Stem cells, like other medical products that are intended to treat, cure or prevent disease, generally require FDA approval before they can be marketed. FDA has not approved any stem cell-based products for use, other than cord blood-derived hematopoietic progenitor cells (blood forming stem cells) for certain indications.


This site is not intended for consumers.

If you are considering stem cell treatment in the U.S., ask your physician if the necessary FDA approval has been obtained or if you will be part of an FDA-regulated clinical study. This also applies if the stem cells are your own. Even if the cells are yours, there are safety risks, including risks introduced when the cells are manipulated after removal.

“There is a potential safety risk when you put cells in an area where they are not performing the same biological function as they were when in their original location in the body.” Cells in a different environment may multiply, form tumors, or may leave the site you put them in and migrate somewhere else.

If you are considering having stem cell treatment in another country, learn all you can about regulations covering the products in that country. Exercise caution before undergoing treatment with a stem cell-based product in a country that—unlike the U.S.—may not require clinical studies designed to demonstrate that the product is safe and effective. FDA does not regulate stem cell treatments used solely in countries other than the United States and typically has little information about foreign establishments or their stem cell products.


Stem cell therapies have enormous promise, but the science in each use is still in the developmental stage.  Professional judgment and expertise is needed in using stem cells for any therapeutic use, and we urge anyone embarking on the use of stem cell therapies to consult the national health data bases to evaluate current information from clinical trials and the FDA websites on human tissue should also be consulted to get its current evaluation of any therapy.